Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis

Eur J Neurol. 2010 Apr;17(4):562-6. doi: 10.1111/j.1468-1331.2009.02853.x. Epub 2009 Nov 24.

Abstract

Background: The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS).

Methods: We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALS patients and 20 controls.

Results: Serum levels of anti-NFL were higher in ALS patients than in controls (P < 0.005). Serum anti-NFL antibodies and intrathecal anti-NFM antibodies were related to patient disability (serum anti-NFL: P < 0.05; intrathecal anti-NFM: P < 0.05). Anti-NFL levels were significantly correlated with anti-NFM levels in ALS (P < 0.001) and the control group (P < 0.0001) in the CSF, but not in serum. Anti-NFL and anti-NFM antibodies significantly correlated between serum and CSF in the ALS group (anti-NFL: P < 0.0001; anti-NFM: P < 0.001) and in the control group (anti-NFL: P < 0.05; anti-NFM: P < 0.05).

Conclusions: Autoimmune humoral response to neurocytoskeletal proteins is associated with ALS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Amyotrophic Lateral Sclerosis / blood
  • Amyotrophic Lateral Sclerosis / cerebrospinal fluid
  • Amyotrophic Lateral Sclerosis / immunology*
  • Autoantibodies / blood*
  • Autoantibodies / cerebrospinal fluid*
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulin G / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Neurofilament Proteins / immunology*
  • Severity of Illness Index
  • Time Factors

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Neurofilament Proteins
  • neurofilament protein L
  • neurofilament protein M